https://www.selleckchem.com/pr....oducts/cdk2-inhibito
Emerging therapeutics that are promising for overcoming drug resistance are also discussed.Therapeutic targeting of blood coagulation is a challenging task as it interferes with the delicate balance of pro- and anticoagulant activities. Anticoagulants are employed in millions of thrombophilic patients worldwide each year. The treatment and prevention of venous thromboembolism has changed drastically. Traditional vitamin K antagonists are being replaced by direct oral anticoagulants (DOACs), which selectively target coagulation
Like
Comment
Share
